You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy

 

Online download statistics by month:

Online download statistics by month: November 2021 to July 2025

AbstractFullPdf
Nov 202125725887
Dec 2021856872297
Jan 2022260279114
Feb 2022141168115
Mar 202217018481
Apr 202215416996
May 2022410438155
Jun 202220221796
Jul 202212713458
Aug 202212914342
Sep 202214915772
Oct 202212213675
Nov 202213714579
Dec 2022909348
Jan 2023848641
Feb 202317617781
Mar 202312012468
Apr 2023666838
May 2023646634
Jun 2023626234
Jul 2023575838
Aug 2023606138
Sep 2023555735
Oct 2023565635
Nov 2023797928
Dec 2023808035
Jan 2024636535
Feb 2024949731
Mar 20248284112
Apr 2024545439
May 2024686846
Jun 2024525340
Jul 2024485043
Aug 2024363323
Sep 2024595940
Oct 20244041274
Nov 2024798144
Dec 2024838839
Jan 2025737463
Feb 202525725736
Mar 202511111342
Apr 2025868747
May 2025555640
Jun 2025343523
Jul 2025110
Total553857632937